nodes	percent_of_prediction	percent_of_DWPC	metapath
Melphalan—Alkylating Activity—Thiotepa—sarcoma	0.335	0.556	CiPCiCtD
Melphalan—peripheral nervous system neoplasm—sarcoma	0.272	1	CtDrD
Melphalan—Alkylating Activity—Dacarbazine—sarcoma	0.268	0.444	CiPCiCtD
Melphalan—SLC22A3—Vincristine—sarcoma	0.0598	1	CbGbCtD
Melphalan—SLC7A5—mammary gland—sarcoma	0.00106	0.0949	CbGeAlD
Melphalan—SLC7A5—myometrium—sarcoma	0.000755	0.0673	CbGeAlD
Melphalan—SLC7A5—seminal vesicle—sarcoma	0.000682	0.0608	CbGeAlD
Melphalan—SLC7A5—hematopoietic system—sarcoma	0.000648	0.0578	CbGeAlD
Melphalan—SLC7A5—connective tissue—sarcoma	0.000624	0.0557	CbGeAlD
Melphalan—SLC7A5—smooth muscle tissue—sarcoma	0.000571	0.0509	CbGeAlD
Melphalan—SLC7A5—skin of body—sarcoma	0.000563	0.0503	CbGeAlD
Melphalan—SLC7A5—cardiac atrium—sarcoma	0.000492	0.0439	CbGeAlD
Melphalan—SLC7A5—uterus—sarcoma	0.000489	0.0437	CbGeAlD
Melphalan—SLC22A3—myometrium—sarcoma	0.000468	0.0418	CbGeAlD
Melphalan—SLC7A5—lymphoid tissue—sarcoma	0.000456	0.0407	CbGeAlD
Melphalan—SLC22A3—embryo—sarcoma	0.00045	0.0402	CbGeAlD
Melphalan—SLC7A5—tendon—sarcoma	0.000429	0.0383	CbGeAlD
Melphalan—SLC22A3—seminal vesicle—sarcoma	0.000423	0.0378	CbGeAlD
Melphalan—SLC7A5—bone marrow—sarcoma	0.000415	0.0371	CbGeAlD
Melphalan—SLC22A3—hematopoietic system—sarcoma	0.000402	0.0359	CbGeAlD
Melphalan—SLC22A3—connective tissue—sarcoma	0.000387	0.0345	CbGeAlD
Melphalan—SLC7A5—testis—sarcoma	0.000355	0.0317	CbGeAlD
Melphalan—SLC22A3—smooth muscle tissue—sarcoma	0.000354	0.0316	CbGeAlD
Melphalan—SLC7A5—liver—sarcoma	0.000336	0.0299	CbGeAlD
Melphalan—SLC7A5—lymph node—sarcoma	0.000257	0.023	CbGeAlD
Melphalan—SLC22A3—testis—sarcoma	0.00022	0.0197	CbGeAlD
Melphalan—SLC22A3—liver—sarcoma	0.000208	0.0186	CbGeAlD
Melphalan—SLC22A3—lymph node—sarcoma	0.00016	0.0143	CbGeAlD
Melphalan—Arrhythmia—Mitoxantrone—sarcoma	9.19e-05	0.00171	CcSEcCtD
Melphalan—Skin exfoliation—Epirubicin—sarcoma	9.12e-05	0.00169	CcSEcCtD
Melphalan—Alopecia—Mitoxantrone—sarcoma	9.09e-05	0.00169	CcSEcCtD
Melphalan—Cough—Thiotepa—sarcoma	9.05e-05	0.00168	CcSEcCtD
Melphalan—Hepatobiliary disease—Etoposide—sarcoma	9.02e-05	0.00167	CcSEcCtD
Melphalan—Blood uric acid increased—Doxorubicin—sarcoma	9e-05	0.00167	CcSEcCtD
Melphalan—Convulsion—Thiotepa—sarcoma	8.99e-05	0.00167	CcSEcCtD
Melphalan—Neuropathy—Epirubicin—sarcoma	8.97e-05	0.00166	CcSEcCtD
Melphalan—Hepatocellular injury—Doxorubicin—sarcoma	8.84e-05	0.00164	CcSEcCtD
Melphalan—Myalgia—Thiotepa—sarcoma	8.83e-05	0.00164	CcSEcCtD
Melphalan—Injection site reaction—Doxorubicin—sarcoma	8.79e-05	0.00163	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	8.77e-05	0.00163	CcSEcCtD
Melphalan—Myalgia—Dactinomycin—sarcoma	8.77e-05	0.00163	CcSEcCtD
Melphalan—Mouth ulceration—Epirubicin—sarcoma	8.64e-05	0.0016	CcSEcCtD
Melphalan—Bladder pain—Epirubicin—sarcoma	8.64e-05	0.0016	CcSEcCtD
Melphalan—Neoplasm—Epirubicin—sarcoma	8.64e-05	0.0016	CcSEcCtD
Melphalan—Cystitis noninfective—Doxorubicin—sarcoma	8.64e-05	0.0016	CcSEcCtD
Melphalan—Cystitis—Doxorubicin—sarcoma	8.54e-05	0.00158	CcSEcCtD
Melphalan—Anaemia—Vincristine—sarcoma	8.5e-05	0.00158	CcSEcCtD
Melphalan—Urinary tract disorder—Etoposide—sarcoma	8.45e-05	0.00157	CcSEcCtD
Melphalan—Skin exfoliation—Doxorubicin—sarcoma	8.44e-05	0.00157	CcSEcCtD
Melphalan—Infection—Thiotepa—sarcoma	8.41e-05	0.00156	CcSEcCtD
Melphalan—Oedema—Dactinomycin—sarcoma	8.4e-05	0.00156	CcSEcCtD
Melphalan—Urethral disorder—Etoposide—sarcoma	8.39e-05	0.00156	CcSEcCtD
Melphalan—Infection—Dactinomycin—sarcoma	8.35e-05	0.00155	CcSEcCtD
Melphalan—Neuropathy—Doxorubicin—sarcoma	8.3e-05	0.00154	CcSEcCtD
Melphalan—Thrombocytopenia—Thiotepa—sarcoma	8.29e-05	0.00154	CcSEcCtD
Melphalan—Anaemia—Mitoxantrone—sarcoma	8.28e-05	0.00154	CcSEcCtD
Melphalan—Tachycardia—Thiotepa—sarcoma	8.26e-05	0.00153	CcSEcCtD
Melphalan—Leukopenia—Vincristine—sarcoma	8.23e-05	0.00153	CcSEcCtD
Melphalan—Thrombocytopenia—Dactinomycin—sarcoma	8.23e-05	0.00153	CcSEcCtD
Melphalan—Skin disorder—Thiotepa—sarcoma	8.22e-05	0.00153	CcSEcCtD
Melphalan—Anorexia—Thiotepa—sarcoma	8.07e-05	0.0015	CcSEcCtD
Melphalan—Leukopenia—Mitoxantrone—sarcoma	8.02e-05	0.00149	CcSEcCtD
Melphalan—Anorexia—Dactinomycin—sarcoma	8.01e-05	0.00149	CcSEcCtD
Melphalan—Bladder pain—Doxorubicin—sarcoma	7.99e-05	0.00148	CcSEcCtD
Melphalan—Mouth ulceration—Doxorubicin—sarcoma	7.99e-05	0.00148	CcSEcCtD
Melphalan—Neoplasm—Doxorubicin—sarcoma	7.99e-05	0.00148	CcSEcCtD
Melphalan—Convulsion—Vincristine—sarcoma	7.97e-05	0.00148	CcSEcCtD
Melphalan—Flushing—Etoposide—sarcoma	7.95e-05	0.00147	CcSEcCtD
Melphalan—Myalgia—Vincristine—sarcoma	7.83e-05	0.00145	CcSEcCtD
Melphalan—Cough—Mitoxantrone—sarcoma	7.82e-05	0.00145	CcSEcCtD
Melphalan—Convulsion—Mitoxantrone—sarcoma	7.76e-05	0.00144	CcSEcCtD
Melphalan—Immune system disorder—Etoposide—sarcoma	7.73e-05	0.00143	CcSEcCtD
Melphalan—Mediastinal disorder—Etoposide—sarcoma	7.72e-05	0.00143	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Thiotepa—sarcoma	7.71e-05	0.00143	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Dactinomycin—sarcoma	7.66e-05	0.00142	CcSEcCtD
Melphalan—Myalgia—Mitoxantrone—sarcoma	7.63e-05	0.00142	CcSEcCtD
Melphalan—Chest pain—Mitoxantrone—sarcoma	7.63e-05	0.00142	CcSEcCtD
Melphalan—Paraesthesia—Thiotepa—sarcoma	7.6e-05	0.00141	CcSEcCtD
Melphalan—Alopecia—Etoposide—sarcoma	7.56e-05	0.0014	CcSEcCtD
Melphalan—Renal failure acute—Epirubicin—sarcoma	7.51e-05	0.00139	CcSEcCtD
Melphalan—Oedema—Vincristine—sarcoma	7.51e-05	0.00139	CcSEcCtD
Melphalan—Anaphylactic shock—Vincristine—sarcoma	7.51e-05	0.00139	CcSEcCtD
Melphalan—Infection—Vincristine—sarcoma	7.46e-05	0.00138	CcSEcCtD
Melphalan—Dyspepsia—Thiotepa—sarcoma	7.45e-05	0.00138	CcSEcCtD
Melphalan—Decreased appetite—Thiotepa—sarcoma	7.36e-05	0.00137	CcSEcCtD
Melphalan—Thrombocytopenia—Vincristine—sarcoma	7.35e-05	0.00136	CcSEcCtD
Melphalan—Oedema—Mitoxantrone—sarcoma	7.31e-05	0.00136	CcSEcCtD
Melphalan—Anaphylactic shock—Mitoxantrone—sarcoma	7.31e-05	0.00136	CcSEcCtD
Melphalan—Gastrointestinal disorder—Thiotepa—sarcoma	7.31e-05	0.00136	CcSEcCtD
Melphalan—Decreased appetite—Dactinomycin—sarcoma	7.31e-05	0.00136	CcSEcCtD
Melphalan—Fatigue—Thiotepa—sarcoma	7.3e-05	0.00135	CcSEcCtD
Melphalan—Infection—Mitoxantrone—sarcoma	7.26e-05	0.00135	CcSEcCtD
Melphalan—Fatigue—Dactinomycin—sarcoma	7.25e-05	0.00134	CcSEcCtD
Melphalan—Pain—Thiotepa—sarcoma	7.24e-05	0.00134	CcSEcCtD
Melphalan—Pain—Dactinomycin—sarcoma	7.19e-05	0.00133	CcSEcCtD
Melphalan—Thrombocytopenia—Mitoxantrone—sarcoma	7.16e-05	0.00133	CcSEcCtD
Melphalan—Anorexia—Vincristine—sarcoma	7.16e-05	0.00133	CcSEcCtD
Melphalan—Tachycardia—Mitoxantrone—sarcoma	7.14e-05	0.00132	CcSEcCtD
Melphalan—Skin disorder—Mitoxantrone—sarcoma	7.1e-05	0.00132	CcSEcCtD
Melphalan—Hypotension—Vincristine—sarcoma	7.02e-05	0.0013	CcSEcCtD
Melphalan—Anorexia—Mitoxantrone—sarcoma	6.97e-05	0.00129	CcSEcCtD
Melphalan—Hyponatraemia—Epirubicin—sarcoma	6.96e-05	0.00129	CcSEcCtD
Melphalan—Renal failure acute—Doxorubicin—sarcoma	6.95e-05	0.00129	CcSEcCtD
Melphalan—Anaemia—Etoposide—sarcoma	6.89e-05	0.00128	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Vincristine—sarcoma	6.84e-05	0.00127	CcSEcCtD
Melphalan—Hypotension—Mitoxantrone—sarcoma	6.83e-05	0.00127	CcSEcCtD
Melphalan—Paraesthesia—Vincristine—sarcoma	6.74e-05	0.00125	CcSEcCtD
Melphalan—Urticaria—Thiotepa—sarcoma	6.73e-05	0.00125	CcSEcCtD
Melphalan—Leukopenia—Etoposide—sarcoma	6.67e-05	0.00124	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Mitoxantrone—sarcoma	6.66e-05	0.00124	CcSEcCtD
Melphalan—Cardiac arrest—Epirubicin—sarcoma	6.6e-05	0.00122	CcSEcCtD
Melphalan—Paraesthesia—Mitoxantrone—sarcoma	6.57e-05	0.00122	CcSEcCtD
Melphalan—Decreased appetite—Vincristine—sarcoma	6.53e-05	0.00121	CcSEcCtD
Melphalan—Dyspnoea—Mitoxantrone—sarcoma	6.52e-05	0.00121	CcSEcCtD
Melphalan—Cough—Etoposide—sarcoma	6.5e-05	0.00121	CcSEcCtD
Melphalan—Gastrointestinal disorder—Vincristine—sarcoma	6.48e-05	0.0012	CcSEcCtD
Melphalan—Fatigue—Vincristine—sarcoma	6.47e-05	0.0012	CcSEcCtD
Melphalan—Convulsion—Etoposide—sarcoma	6.46e-05	0.0012	CcSEcCtD
Melphalan—Hyponatraemia—Doxorubicin—sarcoma	6.44e-05	0.0012	CcSEcCtD
Melphalan—Dyspepsia—Mitoxantrone—sarcoma	6.44e-05	0.00119	CcSEcCtD
Melphalan—Pain—Vincristine—sarcoma	6.42e-05	0.00119	CcSEcCtD
Melphalan—Liver function test abnormal—Epirubicin—sarcoma	6.4e-05	0.00119	CcSEcCtD
Melphalan—Decreased appetite—Mitoxantrone—sarcoma	6.36e-05	0.00118	CcSEcCtD
Melphalan—Chest pain—Etoposide—sarcoma	6.34e-05	0.00118	CcSEcCtD
Melphalan—Fatigue—Mitoxantrone—sarcoma	6.3e-05	0.00117	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	6.3e-05	0.00117	CcSEcCtD
Melphalan—Pain—Mitoxantrone—sarcoma	6.25e-05	0.00116	CcSEcCtD
Melphalan—Hypersensitivity—Thiotepa—sarcoma	6.24e-05	0.00116	CcSEcCtD
Melphalan—Hypersensitivity—Dactinomycin—sarcoma	6.19e-05	0.00115	CcSEcCtD
Melphalan—Cardiac arrest—Doxorubicin—sarcoma	6.1e-05	0.00113	CcSEcCtD
Melphalan—Anaphylactic shock—Etoposide—sarcoma	6.08e-05	0.00113	CcSEcCtD
Melphalan—Asthenia—Thiotepa—sarcoma	6.08e-05	0.00113	CcSEcCtD
Melphalan—Infection—Etoposide—sarcoma	6.04e-05	0.00112	CcSEcCtD
Melphalan—Asthenia—Dactinomycin—sarcoma	6.03e-05	0.00112	CcSEcCtD
Melphalan—Pruritus—Thiotepa—sarcoma	5.99e-05	0.00111	CcSEcCtD
Melphalan—Thrombocytopenia—Etoposide—sarcoma	5.96e-05	0.0011	CcSEcCtD
Melphalan—Tachycardia—Etoposide—sarcoma	5.94e-05	0.0011	CcSEcCtD
Melphalan—Liver function test abnormal—Doxorubicin—sarcoma	5.93e-05	0.0011	CcSEcCtD
Melphalan—Skin disorder—Etoposide—sarcoma	5.91e-05	0.0011	CcSEcCtD
Melphalan—Urticaria—Mitoxantrone—sarcoma	5.81e-05	0.00108	CcSEcCtD
Melphalan—Anorexia—Etoposide—sarcoma	5.8e-05	0.00108	CcSEcCtD
Melphalan—Diarrhoea—Thiotepa—sarcoma	5.79e-05	0.00107	CcSEcCtD
Melphalan—Diarrhoea—Dactinomycin—sarcoma	5.75e-05	0.00107	CcSEcCtD
Melphalan—Pancytopenia—Epirubicin—sarcoma	5.69e-05	0.00106	CcSEcCtD
Melphalan—Hypotension—Etoposide—sarcoma	5.68e-05	0.00105	CcSEcCtD
Melphalan—Neutropenia—Epirubicin—sarcoma	5.61e-05	0.00104	CcSEcCtD
Melphalan—Hypersensitivity—Vincristine—sarcoma	5.53e-05	0.00103	CcSEcCtD
Melphalan—Paraesthesia—Etoposide—sarcoma	5.46e-05	0.00101	CcSEcCtD
Melphalan—Dyspnoea—Etoposide—sarcoma	5.42e-05	0.00101	CcSEcCtD
Melphalan—Hypersensitivity—Mitoxantrone—sarcoma	5.39e-05	0.000999	CcSEcCtD
Melphalan—Asthenia—Vincristine—sarcoma	5.39e-05	0.000999	CcSEcCtD
Melphalan—Vomiting—Thiotepa—sarcoma	5.38e-05	0.000999	CcSEcCtD
Melphalan—Vomiting—Dactinomycin—sarcoma	5.34e-05	0.000991	CcSEcCtD
Melphalan—Rash—Thiotepa—sarcoma	5.34e-05	0.00099	CcSEcCtD
Melphalan—Dermatitis—Thiotepa—sarcoma	5.33e-05	0.000989	CcSEcCtD
Melphalan—Rash—Dactinomycin—sarcoma	5.3e-05	0.000983	CcSEcCtD
Melphalan—Decreased appetite—Etoposide—sarcoma	5.29e-05	0.000981	CcSEcCtD
Melphalan—Pancytopenia—Doxorubicin—sarcoma	5.27e-05	0.000977	CcSEcCtD
Melphalan—Gastrointestinal disorder—Etoposide—sarcoma	5.25e-05	0.000974	CcSEcCtD
Melphalan—Asthenia—Mitoxantrone—sarcoma	5.25e-05	0.000973	CcSEcCtD
Melphalan—Fatigue—Etoposide—sarcoma	5.24e-05	0.000973	CcSEcCtD
Melphalan—Neuropathy peripheral—Epirubicin—sarcoma	5.24e-05	0.000972	CcSEcCtD
Melphalan—Stomatitis—Epirubicin—sarcoma	5.21e-05	0.000967	CcSEcCtD
Melphalan—Jaundice—Epirubicin—sarcoma	5.21e-05	0.000967	CcSEcCtD
Melphalan—Pain—Etoposide—sarcoma	5.2e-05	0.000965	CcSEcCtD
Melphalan—Neutropenia—Doxorubicin—sarcoma	5.19e-05	0.000962	CcSEcCtD
Melphalan—Diarrhoea—Vincristine—sarcoma	5.14e-05	0.000953	CcSEcCtD
Melphalan—Hepatobiliary disease—Epirubicin—sarcoma	5.06e-05	0.000938	CcSEcCtD
Melphalan—Nausea—Thiotepa—sarcoma	5.03e-05	0.000933	CcSEcCtD
Melphalan—Diarrhoea—Mitoxantrone—sarcoma	5e-05	0.000928	CcSEcCtD
Melphalan—Nausea—Dactinomycin—sarcoma	4.99e-05	0.000926	CcSEcCtD
Melphalan—Neuropathy peripheral—Doxorubicin—sarcoma	4.85e-05	0.000899	CcSEcCtD
Melphalan—Urticaria—Etoposide—sarcoma	4.83e-05	0.000896	CcSEcCtD
Melphalan—Haemoglobin—Epirubicin—sarcoma	4.82e-05	0.000895	CcSEcCtD
Melphalan—Jaundice—Doxorubicin—sarcoma	4.82e-05	0.000894	CcSEcCtD
Melphalan—Stomatitis—Doxorubicin—sarcoma	4.82e-05	0.000894	CcSEcCtD
Melphalan—Haemorrhage—Epirubicin—sarcoma	4.8e-05	0.00089	CcSEcCtD
Melphalan—Hepatitis—Epirubicin—sarcoma	4.8e-05	0.00089	CcSEcCtD
Melphalan—Vomiting—Vincristine—sarcoma	4.77e-05	0.000886	CcSEcCtD
Melphalan—Urinary tract disorder—Epirubicin—sarcoma	4.74e-05	0.000879	CcSEcCtD
Melphalan—Rash—Vincristine—sarcoma	4.73e-05	0.000878	CcSEcCtD
Melphalan—Dermatitis—Vincristine—sarcoma	4.73e-05	0.000877	CcSEcCtD
Melphalan—Connective tissue disorder—Epirubicin—sarcoma	4.72e-05	0.000875	CcSEcCtD
Melphalan—Urethral disorder—Epirubicin—sarcoma	4.7e-05	0.000873	CcSEcCtD
Melphalan—Hepatobiliary disease—Doxorubicin—sarcoma	4.68e-05	0.000868	CcSEcCtD
Melphalan—Vomiting—Mitoxantrone—sarcoma	4.65e-05	0.000862	CcSEcCtD
Melphalan—Rash—Mitoxantrone—sarcoma	4.61e-05	0.000855	CcSEcCtD
Melphalan—Dermatitis—Mitoxantrone—sarcoma	4.61e-05	0.000854	CcSEcCtD
Melphalan—Hypersensitivity—Etoposide—sarcoma	4.48e-05	0.000831	CcSEcCtD
Melphalan—Haemoglobin—Doxorubicin—sarcoma	4.46e-05	0.000828	CcSEcCtD
Melphalan—Nausea—Vincristine—sarcoma	4.46e-05	0.000827	CcSEcCtD
Melphalan—Flushing—Epirubicin—sarcoma	4.45e-05	0.000826	CcSEcCtD
Melphalan—Haemorrhage—Doxorubicin—sarcoma	4.44e-05	0.000824	CcSEcCtD
Melphalan—Hepatitis—Doxorubicin—sarcoma	4.44e-05	0.000824	CcSEcCtD
Melphalan—Urinary tract disorder—Doxorubicin—sarcoma	4.39e-05	0.000813	CcSEcCtD
Melphalan—Asthenia—Etoposide—sarcoma	4.36e-05	0.00081	CcSEcCtD
Melphalan—Connective tissue disorder—Doxorubicin—sarcoma	4.36e-05	0.000809	CcSEcCtD
Melphalan—Urethral disorder—Doxorubicin—sarcoma	4.35e-05	0.000807	CcSEcCtD
Melphalan—Nausea—Mitoxantrone—sarcoma	4.34e-05	0.000806	CcSEcCtD
Melphalan—Immune system disorder—Epirubicin—sarcoma	4.33e-05	0.000804	CcSEcCtD
Melphalan—Mediastinal disorder—Epirubicin—sarcoma	4.32e-05	0.000802	CcSEcCtD
Melphalan—Pruritus—Etoposide—sarcoma	4.3e-05	0.000798	CcSEcCtD
Melphalan—Arrhythmia—Epirubicin—sarcoma	4.29e-05	0.000795	CcSEcCtD
Melphalan—Alopecia—Epirubicin—sarcoma	4.24e-05	0.000787	CcSEcCtD
Melphalan—Diarrhoea—Etoposide—sarcoma	4.16e-05	0.000772	CcSEcCtD
Melphalan—Flushing—Doxorubicin—sarcoma	4.12e-05	0.000764	CcSEcCtD
Melphalan—Immune system disorder—Doxorubicin—sarcoma	4.01e-05	0.000744	CcSEcCtD
Melphalan—Mediastinal disorder—Doxorubicin—sarcoma	4e-05	0.000742	CcSEcCtD
Melphalan—Arrhythmia—Doxorubicin—sarcoma	3.97e-05	0.000736	CcSEcCtD
Melphalan—Alopecia—Doxorubicin—sarcoma	3.92e-05	0.000728	CcSEcCtD
Melphalan—Vomiting—Etoposide—sarcoma	3.87e-05	0.000717	CcSEcCtD
Melphalan—Anaemia—Epirubicin—sarcoma	3.86e-05	0.000716	CcSEcCtD
Melphalan—Rash—Etoposide—sarcoma	3.83e-05	0.000711	CcSEcCtD
Melphalan—Dermatitis—Etoposide—sarcoma	3.83e-05	0.000711	CcSEcCtD
Melphalan—Leukopenia—Epirubicin—sarcoma	3.74e-05	0.000694	CcSEcCtD
Melphalan—Cough—Epirubicin—sarcoma	3.65e-05	0.000676	CcSEcCtD
Melphalan—Convulsion—Epirubicin—sarcoma	3.62e-05	0.000671	CcSEcCtD
Melphalan—Nausea—Etoposide—sarcoma	3.61e-05	0.00067	CcSEcCtD
Melphalan—Anaemia—Doxorubicin—sarcoma	3.57e-05	0.000663	CcSEcCtD
Melphalan—Chest pain—Epirubicin—sarcoma	3.56e-05	0.00066	CcSEcCtD
Melphalan—Myalgia—Epirubicin—sarcoma	3.56e-05	0.00066	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	3.53e-05	0.000655	CcSEcCtD
Melphalan—Leukopenia—Doxorubicin—sarcoma	3.46e-05	0.000642	CcSEcCtD
Melphalan—Oedema—Epirubicin—sarcoma	3.41e-05	0.000632	CcSEcCtD
Melphalan—Anaphylactic shock—Epirubicin—sarcoma	3.41e-05	0.000632	CcSEcCtD
Melphalan—Infection—Epirubicin—sarcoma	3.39e-05	0.000628	CcSEcCtD
Melphalan—Cough—Doxorubicin—sarcoma	3.37e-05	0.000626	CcSEcCtD
Melphalan—Convulsion—Doxorubicin—sarcoma	3.35e-05	0.000621	CcSEcCtD
Melphalan—Thrombocytopenia—Epirubicin—sarcoma	3.34e-05	0.000619	CcSEcCtD
Melphalan—Tachycardia—Epirubicin—sarcoma	3.33e-05	0.000617	CcSEcCtD
Melphalan—Skin disorder—Epirubicin—sarcoma	3.31e-05	0.000614	CcSEcCtD
Melphalan—Chest pain—Doxorubicin—sarcoma	3.29e-05	0.00061	CcSEcCtD
Melphalan—Myalgia—Doxorubicin—sarcoma	3.29e-05	0.00061	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	3.27e-05	0.000606	CcSEcCtD
Melphalan—Anorexia—Epirubicin—sarcoma	3.25e-05	0.000603	CcSEcCtD
Melphalan—Hypotension—Epirubicin—sarcoma	3.19e-05	0.000591	CcSEcCtD
Melphalan—Oedema—Doxorubicin—sarcoma	3.15e-05	0.000585	CcSEcCtD
Melphalan—Anaphylactic shock—Doxorubicin—sarcoma	3.15e-05	0.000585	CcSEcCtD
Melphalan—Infection—Doxorubicin—sarcoma	3.13e-05	0.000581	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Epirubicin—sarcoma	3.11e-05	0.000576	CcSEcCtD
Melphalan—Thrombocytopenia—Doxorubicin—sarcoma	3.09e-05	0.000573	CcSEcCtD
Melphalan—Tachycardia—Doxorubicin—sarcoma	3.08e-05	0.000571	CcSEcCtD
Melphalan—Skin disorder—Doxorubicin—sarcoma	3.06e-05	0.000568	CcSEcCtD
Melphalan—Paraesthesia—Epirubicin—sarcoma	3.06e-05	0.000568	CcSEcCtD
Melphalan—Dyspnoea—Epirubicin—sarcoma	3.04e-05	0.000564	CcSEcCtD
Melphalan—Anorexia—Doxorubicin—sarcoma	3.01e-05	0.000558	CcSEcCtD
Melphalan—Dyspepsia—Epirubicin—sarcoma	3e-05	0.000557	CcSEcCtD
Melphalan—Decreased appetite—Epirubicin—sarcoma	2.96e-05	0.00055	CcSEcCtD
Melphalan—Hypotension—Doxorubicin—sarcoma	2.95e-05	0.000547	CcSEcCtD
Melphalan—Gastrointestinal disorder—Epirubicin—sarcoma	2.94e-05	0.000546	CcSEcCtD
Melphalan—Fatigue—Epirubicin—sarcoma	2.94e-05	0.000545	CcSEcCtD
Melphalan—Pain—Epirubicin—sarcoma	2.92e-05	0.000541	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Doxorubicin—sarcoma	2.87e-05	0.000533	CcSEcCtD
Melphalan—Paraesthesia—Doxorubicin—sarcoma	2.83e-05	0.000525	CcSEcCtD
Melphalan—Dyspnoea—Doxorubicin—sarcoma	2.81e-05	0.000522	CcSEcCtD
Melphalan—Dyspepsia—Doxorubicin—sarcoma	2.78e-05	0.000515	CcSEcCtD
Melphalan—Decreased appetite—Doxorubicin—sarcoma	2.74e-05	0.000509	CcSEcCtD
Melphalan—Gastrointestinal disorder—Doxorubicin—sarcoma	2.72e-05	0.000505	CcSEcCtD
Melphalan—Fatigue—Doxorubicin—sarcoma	2.72e-05	0.000505	CcSEcCtD
Melphalan—Urticaria—Epirubicin—sarcoma	2.71e-05	0.000502	CcSEcCtD
Melphalan—Pain—Doxorubicin—sarcoma	2.7e-05	0.0005	CcSEcCtD
Melphalan—Hypersensitivity—Epirubicin—sarcoma	2.51e-05	0.000466	CcSEcCtD
Melphalan—Urticaria—Doxorubicin—sarcoma	2.51e-05	0.000465	CcSEcCtD
Melphalan—Asthenia—Epirubicin—sarcoma	2.45e-05	0.000454	CcSEcCtD
Melphalan—Pruritus—Epirubicin—sarcoma	2.41e-05	0.000447	CcSEcCtD
Melphalan—Diarrhoea—Epirubicin—sarcoma	2.33e-05	0.000433	CcSEcCtD
Melphalan—Hypersensitivity—Doxorubicin—sarcoma	2.32e-05	0.000431	CcSEcCtD
Melphalan—Asthenia—Doxorubicin—sarcoma	2.26e-05	0.00042	CcSEcCtD
Melphalan—Pruritus—Doxorubicin—sarcoma	2.23e-05	0.000414	CcSEcCtD
Melphalan—Vomiting—Epirubicin—sarcoma	2.17e-05	0.000402	CcSEcCtD
Melphalan—Diarrhoea—Doxorubicin—sarcoma	2.16e-05	0.0004	CcSEcCtD
Melphalan—Rash—Epirubicin—sarcoma	2.15e-05	0.000399	CcSEcCtD
Melphalan—Dermatitis—Epirubicin—sarcoma	2.15e-05	0.000398	CcSEcCtD
Melphalan—Nausea—Epirubicin—sarcoma	2.03e-05	0.000376	CcSEcCtD
Melphalan—Vomiting—Doxorubicin—sarcoma	2.01e-05	0.000372	CcSEcCtD
Melphalan—Rash—Doxorubicin—sarcoma	1.99e-05	0.000369	CcSEcCtD
Melphalan—Dermatitis—Doxorubicin—sarcoma	1.99e-05	0.000369	CcSEcCtD
Melphalan—Nausea—Doxorubicin—sarcoma	1.87e-05	0.000348	CcSEcCtD
